Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

105 results about "Ylide" patented technology

A ylide or ylid (/ˈɪlɪd/) is a neutral dipolar molecule containing a formally negatively charged atom (usually a carbanion) directly attached to a heteroatom with a formal positive charge (usually nitrogen, phosphorus or sulfur), and in which both atoms have full octets of electrons. The result can be viewed as a structure in which two adjacent atoms are connected by both a covalent and an ionic bond; normally written X⁺–Y⁻. Ylides are thus 1,2-dipolar compounds, and a subclass of zwitterions. They appear in organic chemistry as reagents or reactive intermediates.

Well Treatment Fluids Containing An Ylide Or A Vitamin B And Methods Of Using The Same

ActiveUS20140041877A1Enhanced recovery of hydrocarbonPromote recoveryFluid removalFlushingVitamin B12Polymer
Viscosifying polymers are effectively degraded during a well treatment operation with an ylide breaker or a vitamin B cofactor. The vitamin B cofactor is an ylide, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 or vitamin B12 or mixtures thereof. Such breakers are effective at room and elevated temperatures and high pH environments.
Owner:BAKER HUGHES INC

Phosphonium salt compound containing precursor of biphosphorus ylide cyclopentadienyl cyclocarbene as well as preparation method and application thereof

The invention relates to a phosphonium salt compound containing precursor of biphosphorus ylide cyclopentadienyl cyclocarbene as well as a preparation method and application thereof, which belong to the field of organic synthesis. The adopted technical scheme is as follows: the general formula of the phosphonium salt compound containing precursor of biphosphorus ylide cyclopentadienyl cyclocarbene: FORMULA, wherein R is alkyl or aryl, X is selected from F-, Cl-, Br-, I-, PF6-, BF4-, SbF6-, ClO4- or N3-. The preparation method of the phosphonium salt compound comprises the following steps of: adding 1, 1'-ferrocene bimercury compound, tertiary phosphine PR3 and palladium chloride to an organic solvent, refluxing under protection of N2, filtering, evaporating to dryness and recrystallizing to obtain the phosphonium salt compound. In addition, in the invention, the phosphonium salt compound is used as a catalyst ligand so that the phosphonium salt compound and the metal salt act togetherto catalyze and synthesize alpha-aryl derivatives of carbonyl compound by one step. The application test indicates that compared with traditional N-heterocyclocarbene ligand, the phosphonium salt compound has excellent catalytic activity.
Owner:LUOYANG NORMAL UNIV

Preparation method of vitamin A acetate

The invention provides a preparation method for vitamin A acetate. The preparation method comprises the following steps: carrying out an addition reaction on a C15 phosphonium salt and a C5 aldehyde in the presence of an alkali compound to generate an ylide salt; and subjecting the ylide to a decomposition reaction to obtain the vitamin A acetate, wherein the content of ylide in a reaction system in a reaction process is less than or equal to 0.06 mol / L. According to the preparation method, on the basis of a C15 + C5 Wittig reaction, the content of ylide in the reaction system in the reaction process is controlled, and the vitamin A acetate with high purity, high trans-isomerization selectivity and high yield is obtained. The preparation method is suitable for any-scale reaction and can be carried out in batches and conducted semi-continuously or completely continuously; and the obtained vitamin A acetate is low in chromatic value, good in oxidation resistance and thermal stability, low in deterioration rate, beneficial to long-term stable storage and very good in market competitiveness.
Owner:WANHUA CHEM GRP CO LTD

Solvent-free mechanochemical preparation of phosphonium salts, phosphorus ylides, and olefins

The present invention provides a method of preparing a phosphonium salt of the formula [R1R2R3P—CR4R5R6]X, comprising ball-milling a phosphine of the formula R1R2R3P with a compound of the formula XCR4R5R6; a method of preparing a phosphorus ylide of the formula R1R2R3P═CR4R5, comprising ball-milling a phosphonium salt of the formula [R1R2R3P—HCR4R5]X in the presence of a base; and a method of preparing an olefin of the formula R4R5C═CR7H or R4R5C═CR7R8, comprising ball-milling a phosphorus ylide of the formula R1R2R3P═CR4R5 with a compound of the formula R7C(O)H or R7C(O)R8. The inventive method produces phosphonium salts and phosphorus ylides by mechanical processing solid reagents under solvent-free conditions. The advantages of the present invention over conventional solution methods, include: (1) extremely high selectivity; (2) high yields; (3) low processing temperatures; (4) simple and scalable reactions using commercially available equipment; and (5) the complete elimination of solvents from the reaction.
Owner:IOWA STATE UNIV RES FOUND

Synthetic method of 4-[1-(2,3-dimethylphenyl)vinyl-1-R1-2-R2 imidazole

The invention relates to a synthetic method of 4-[1-(2,3-dimethylphenyl)vinyl-1-R1-2-R2 imidazole, and mainly solves the technical problems of expensive reagents, complex operations, and no benefit to industrial production for existing synthetic methods. The technical scheme of the invention is that: the synthetic method of 4-[1-(2,3-dimethylphenyl)vinyl-1-R1-2-R2 imidazole allows phosphorus ylide and 2,3-dimethylphenyl-1-R1-2-R2 imidazole-4-ketone to react so as to synthesize 4-[1-(2,3-dimethylphenyl)vinyl-1-R1-2-R2 imidazole. The reaction needs stirring overnight (12-16 hours), and the reaction product is filtered, concentrated, washed and purified by a silica gel column. The product is an important intermediate in pharmaceutical synthesis.
Owner:SUNDIA MEDITECH COMPANY LTD

Preparation method for synthesizing intermediate compound of rosuvastatin calcium

The invention provides a preparation method for synthesizing intermediate compound of rosuvastatin calcium, which relates to a technique for synthesizing intermediate compound of Rosuvastatin Calcium. The intermediate compound is (R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino) pyrimidin-5-yl]-3-(tert-butyl dimethyl silicon)oxy-5-carbonyl-6(E)-methyl heptene. The method uses N-[4-(4-fluorophenyl)-5-formoxyl-6-isopropyl pyridine-2-yl]-N-methyl sulfonamide and (3R)-3-(tertiary butyl dimethyl silicon)oxy-5-carbonyl-6-triphenylphosphine ylide methyl caproate as raw material, through Wittig reaction, crude product is produced, and then, the crude product is separated and purified by phase disengagement, adsorption and other postprocessing methods, furthermore, the intermediate compound is (R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino) pyrimidin-5-yl]-3-(tert-butyl dimethyl silicon)oxy-5-carbonyl-6(E)-methyl heptene for synthesizing Rosuvastatin Calcium is obtained. The invention has the advantages of low cost, simple operation and good economic benefit, which is suitable for industrial production. The intermediate compound obtained by method provided by the invention can be used for preparing Rosuvastatin Calcium.
Owner:安徽美诺华药物化学有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products